Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEFree Report) in a report issued on Friday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE opened at $0.00 on Friday. The stock has a market capitalization of $2,951.00, a price-to-earnings ratio of 0.00 and a beta of 3.71. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $2.47. The stock’s 50-day simple moving average is $0.02 and its 200 day simple moving average is $0.02.

About Ampio Pharmaceuticals

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Featured Stories

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.